Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Main Capital and Björn Lundén in connection with the acquisition of Due Compliance AB
Mandate

Vinge has advised Main Capital and Björn Lundén in connection with the acquisition of Due Compliance AB

December 12, 2023 M&A Employment and Benefits Banking and Finance Data protection and processing of personal data Intellectual Property

Due Compliance is a software company which enables organisations to comply with the requirements in relation to Money Laundering and Terrorist Financing (Prevention) Act by providing digital tools for AML, KYC and Risk Assessments.

Björn Lundén, which is a strong provider of software for accounting, invoicing and payroll management, considers the acquisition of Due Compliance as an important step towards expanding its offering of digital tools in the regulatory market. The acquisition strengthens the group’s market position with the goal of becoming a leading player in Europe offering a comprehensive set of cloud-based accounting, ERP and RegTech solutions.
Vinge’s team consisted of Filip Öhrner, Josef Groow (M&A), Arvid Weimers, Karl-Gustaw Tobola, August Ahlin (Banking and Finance), Lisa Hörnqvist (IT and GDPR), Axel Lennartsson (IP), Victor Björkheim (employment) and Jessica Öijer (Transaction Support Senior Specialist).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025